Recursion Pharmaceuticals, Inc. Ratios

Ratios Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -21.16%4.46%23.12%
EBT Margin -2,692.58%-2,135.66%-1,832.18%-601.05%-745.10%-789.93%
EBIT Margin -2,692.58%-2,135.66%-1,795.79%-616.74%-785.33%-814.09%
EBITDA Margin -2,692.58%-2,135.66%-1,795.79%-616.74%-785.33%-814.09%
Operating Margin -2,692.58%-2,135.66%-1,795.79%-616.74%-785.33%-814.09%
Net Margin -2,692.58%-2,135.66%-1,832.18%-601.05%-735.99%-788.02%
FCF Margin -2,628.37%-1,293.03%-1,949.42%-302.65%-672.43%-633.71%
Efficiency
Assets Average 454.46M655.82M677.49M1,051.15M
Equity Average 168.32M514.37M474.62M749.11M
Invested Capital -206.29M542.94M485.81M463.48M1,043.21M
Asset Utilization Ratio 0.020.060.070.06
Leverage & Solvency
Debt to Equity -0.060.000.000.000.03
Debt Ratio 0.040.000.000.000.02
Equity Ratio -0.690.890.690.710.71
Valuation
Enterprise Value -264.13M2,378.29M910.28M1,741.11M1,340.30M
Market Capitalization 2,894.85M1,461.47M2,135.91M1,937.69M
Return Ratios
Return on Sales -26.93%-21.36%-18.32%-6.01%-7.36%-7.88%
Return on Capital Employed -0.45%-0.44%-0.60%-0.55%
Return on Invested Capital -0.73%-0.63%
Return on Assets -0.41%-0.37%-0.48%-0.44%
Return on Equity -1.11%-0.47%-0.69%-0.62%